Antimicrobial Resistance: Prevention and Management Strategies, 2012 Home Study Edition
From Theory to Bedside: Clinical Reasoning Series is one component of the professional development program developed by ACCP and approved by the Board of Pharmacy Specialties (BPS) for the recertification of the Board Certified Pharmacotherapy Specialist (BCPS).
This education series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It provides participants with active learning exercises designed to advance their skills and abilities to critically evaluate scientific evidence and clinical trials and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.
Antimicrobial Resistance: Prevention and Management Strategies” provides an overview of current and emerging antimicrobial resistance patterns. Expert educators and practitioners discuss clinical and cost-effective prevention and management strategies for methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and Clostridium difficile (C. difficile) infections that help inform individual patient care and formulary decisions. Sessions on antimicrobial stewardship and formulary and pharmacoeconomic considerations further guide the provision of cost-effective services that improve patient outcomes.
The Clinical Reasoning Series Program for BCPS Recertification
ACCP, as the official provider approved by BPS, will record and report recertification credit earned for this activity directly to BPS. The program content, developed by clinical and educational experts, is from the live presentation of the From Theory to Bedside: Clinical Reasoning Series. The program is available online. Handouts can be downloaded from our website. This format includes a Web-based posttest. Board Certified Pharmacotherapy Specialists who subscribe to the 2012 online edition and successfully complete the posttest by November 30, 2012, will earn 6.0 hours of recertification credit.
Antimicrobial Resistance: Prevention and Management Strategies covers the following content:
- Antimicrobial Resistance: Mechanisms and Emerging Patterns
- Genomics: Strategies Against Resistance Development and Therapeutic Implications
- Methicillin-resistant Staphylococcus aureus: Microbiology and Clinical Evidence
- Vancomycin-resistant Enterococcal Infections: Microbiology and Clinical Evidence
- Clostridium difficile Infections: Microbiology and Clinical Evidence
- Antimicrobial Stewardship: Lessons Learned and New Opportunities
- Formulary and Pharmacoeconomic Considerations
Elizabeth A. Coyle, Pharm.D., FCCM, BCPS
Clinical Associate Professor of Infectious Diseases
University of Houston College of Pharmacy
Adjunct Assistant Professor
Department of Infectious Diseases, Infection Control and Employee Health
Director of the Infectious Diseases Pharmacy Residency
University of Texas M D Anderson Cancer Center
Erika J. Ernst, Pharm.D., FCCP, BCPS
Associate Professor, Department of Pharmacy Practice and Science
University of Iowa College of Pharmacy
Clinical Pharmacy Specialist
University of Iowa Hospitals and Clinics
Iowa City, Iowa
Michael B. Kays, Pharm.D., FCCP
Associate Professor of Pharmacy Practice
Purdue University College of Pharmacy
Clinical Specialist in Infectious Diseases at IU Health, Methodist Hospital
Adjunct Associate Professor of Medicine
Indiana University School of Medicine
Continuing Pharmacy Education Credit
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This is an application-based activity; Activity Number: 0217-0000-12-087-H01-P.
To earn continuing pharmacy education credit and to receive your continuing pharmacy education statement of credit for this activity, participants must successfully complete a Web-based posttest by November 30, 2012. Partial credit is not available for this activity.
BCPS Recertification Credit
To be eligible for 6.0 CPE hours of recertification credit, BCPSs must successfully complete a Web-based posttest by November 30, 2012. Partial credit is not available for this activity.
Target Audience and Program Goals
The target audience for this program is clinical pharmacists and BCPSs seeking recertification credit by continuing education.
At the conclusion of the program, the participant should be able to:
- Compare and contrast the various mechanisms and emerging patterns of antimicrobial resistance, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and Clostridium difficile (C. difficile).
- Discuss genomic discoveries relevant to antimicrobial resistance and individualized therapy.
- Use resistance patterns, susceptibility data, and new clinical evidence to recommend optimal antimicrobial regimens for the management of MRSA, VRE, and C. difficile infections.
- Design antimicrobial stewardship programs to prevent the emergence of, and/or to eradicate, antimicrobial resistance.
- Apply clinical and pharmacoeconomic data to individual patient care and formulary decisions.
Click here to view the Learning Objectives.
Board Certification FAQs
Link to: http://www.accp.com/careers/boardfaq.aspx.
You will need a sound card, speakers and an internet browser with Flash Player software installed. For instructions on downloading and installing the free Adobe Flash Player, see the Adobe Flash Player download page.
You will need Adobe Reader to view some documents. For instructions on downloading and installing the free Adobe Reader, see the Adobe Flash Player download page.
|Online Program with 6.0 Continuing Education Credits -
Includes audio/slide synchronized presentations, mp3 files of audio, handouts, and online CE test. The ACPE Universal Activity Number is listed under Continuing Education Credit above.